SCHEMBL984226

SCHEMBL984226

COc1cc(OCC2CC2)c(-c2ncnc3c(C(=O)N[C@H]4CC[C@H](NC(C)=O)CC4)c[nH]c23)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 4/20 0.40
CDK9 P50750 3/20 0.36
CASP3 P42574 1/20 0.36
CASP7 P55210 1/20 0.36
BTK Q06187 3/20 0.36
CDK1 P06493 2/20 0.34
CDK2 P24941 2/20 0.34
PTK2 Q05397 1/20 0.34
MAP3K6 O95382 1/20 0.34
MAP3K5 Q99683 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
AXL P30530 1/20 0.34
PDE4B Q07343 2/20 0.33
PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL983983 0.93 BTK (0.43) LRRK2BTKPTK2MAP3K6MAP3K5
SCHEMBL983483 0.92 BTK (0.35) LRRK2CDK9BTKPTK2MAP3K6
SCHEMBL985437 0.92 BTK (0.37) LRRK2BTKPTK2MAP3K6MAP3K5
Hydrochloric Acid SCHEMBL985105 0.91 PTK2 (0.40) CDK2PTK2HTR2AHTR2CHTR2B
SCHEMBL982064 0.91 MAP3K5 (0.37) LRRK2CDK9CASP3CASP7BTK
SCHEMBL982398 0.91 BTK (0.34) LRRK2BTKPTK2MAP3K6MAP3K5
SCHEMBL981748 0.90 BTK (0.39) LRRK2BTKPDE4BRIPK2
SCHEMBL981750 0.90 BTK (0.39) LRRK2BTKPDE4BRIPK2
SCHEMBL985449 0.90 BTK (0.35) LRRK2BTKPTK2MAP3K6MAP3K5
SCHEMBL986220 0.89 PTK2 (0.40) CDK2PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A LRRK2 4219/4885CDK9 639/4885CASP3 1097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.